tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Xenetic Biosciences Announces Public Offering Pricing
PremiumCompany AnnouncementsXenetic Biosciences Announces Public Offering Pricing
2M ago
Xenetic Biosciences trading resumes
Premium
The Fly
Xenetic Biosciences trading resumes
2M ago
Xenetic Biosciences trading halted, volatility trading pause
Premium
The Fly
Xenetic Biosciences trading halted, volatility trading pause
2M ago
Is XBIO a Buy, Before Earnings?
PremiumPre-EarningsIs XBIO a Buy, Before Earnings?
4M ago
Xenetic says PeriNess enters clinical study agreement for DNase Platform
Premium
The Fly
Xenetic says PeriNess enters clinical study agreement for DNase Platform
5M ago
Xenetic expands collaboration with The Scripps Research Institute
Premium
The Fly
Xenetic expands collaboration with The Scripps Research Institute
5M ago
Xenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
PremiumThe FlyXenetic: PeriNess in XBIO-015 study to treat osteosarcoma and Ewing sarcoma
9M ago
Xenetic reports FY24 EPS ($2.57)  vs. ($2.71) last year
Premium
The Fly
Xenetic reports FY24 EPS ($2.57) vs. ($2.71) last year
9M ago
Xenetic presents preclinical data on DNase I with CAR T cells in murine model
Premium
The Fly
Xenetic presents preclinical data on DNase I with CAR T cells in murine model
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100